Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

Weill Medical College of Cornell University · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
progression
chronic lymphocytic leukemia, cll progression, cll/sll, cll, progression, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 802094
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.